19-Dec-2025
RBC Capital Remains a Hold on Aveanna Healthcare Holdings (AVAH)
TipRanks (Fri, 19-Dec 8:49 PM ET)
Aveanna to Participate at the 44th Annual J.P. Morgan Healthcare Conference
Globe Newswire (Wed, 17-Dec 5:00 PM ET)
Aveanna to Participate at the BofA Securities Home Care Conference
Globe Newswire (Thu, 4-Dec 5:00 PM ET)
Aveanna Healthcare Lifts 2025 Outlook Amidst Surging Revenue and Margin Expansion
Market Chameleon (Thu, 6-Nov 3:33 AM ET)
Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook
Globe Newswire (Thu, 6-Nov 6:30 AM ET)
Market Chameleon (Wed, 22-Oct 3:55 AM ET)
Aveanna Announces Pricing of Secondary Offering of Common Stock
Globe Newswire (Tue, 21-Oct 9:50 PM ET)
Aveanna Announces Launch of Secondary Offering of Common Stock
Globe Newswire (Tue, 21-Oct 4:20 PM ET)
Aveanna Healthcare Holdings Announces Preliminary Third Quarter Financial Results
Globe Newswire (Tue, 21-Oct 4:15 PM ET)
Aveanna Announces Third Quarter 2025 Earnings Release Date and Conference Call
Globe Newswire (Thu, 16-Oct 6:30 AM ET)
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
Aveanna Healthcare Hldgs trades on the NASDAQ stock market under the symbol AVAH.
As of December 19, 2025, AVAH stock price climbed to $9.09 with 3,577,393 million shares trading.
AVAH has a beta of 1.08, meaning it tends to be more sensitive to market movements. AVAH has a correlation of 0.06 to the broad based SPY ETF.
AVAH has a market cap of $1.90 billion. This is considered a Small Cap stock.
Last quarter Aveanna Healthcare Hldgs reported $622 million in Revenue and $.15 earnings per share. This beat revenue expectation by $31 million and exceeded earnings estimates by $.04.
In the last 3 years, AVAH traded as high as $10.32 and as low as $.67.
The top ETF exchange traded funds that AVAH belongs to (by Net Assets): VTI, IWM, VXF, SCHA, IWO.
AVAH has outperformed the market in the last year with a return of +101.1%, while the SPY ETF gained +18.1%. In the last 3 month period, AVAH beat the market returning +12.2%, while SPY returned +2.8%. However, in the most recent 2 weeks AVAH has underperformed the stock market by returning -2.4%, while SPY returned -0.5%.
AVAH support price is $8.85 and resistance is $9.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVAH shares will trade within this expected range on the day.